Orris
attachment

Tell me the answers about that questions

Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
I now have comprehensive information from the textbooks. Here are the full, mechanism-based answers for both cases:

STUDENT CARD 08 - Answers

CASE A - Emphysema

Q1: Which biochemical process/molecular concept is primarily disturbed?

The protease-antiprotease imbalance is the primary disturbed mechanism.
Specifically, smoking causes oxidative stress that inactivates alpha-1-antitrypsin (α1-antiprotease), the main inhibitor of neutrophil elastase in lung tissue. Cigarette smoke does this in two ways:
  • Reactive oxygen species (ROS) in smoke directly oxidize and inactivate α1-antitrypsin
  • Smoke recruits large numbers of pulmonary macrophages and neutrophils, which release additional proteases (elastase, matrix metalloproteinases) AND generate more ROS
The result: proteolytic enzymes (especially neutrophil elastase) go unchecked and destroy the elastin and collagen framework of the alveolar walls.

Q2: How does this disturbance produce the clinical/laboratory findings?

  1. Loss of elastic recoil - Elastase degrades elastin in alveolar walls. Elastin provides the "spring-back" tension that normally keeps small airways open during exhalation. Without it, the alveolar walls are destroyed (enlarging air spaces) and small airways collapse during expiration.
  2. Airflow obstruction and air trapping - The collapsed airways trap air in the lungs, causing hyperinflation (barrel chest, increased total lung capacity on PFTs).
  3. Shortness of breath - The patient must use accessory muscles to force air out past collapsed airways. This creates the clinical picture of dyspnea, especially on exertion.
  4. Decreased FEV1/FVC ratio on spirometry - classic obstructive pattern.
  5. Decreased DLCO - The alveolar wall destruction reduces the surface area available for gas exchange, so carbon monoxide diffusing capacity falls.
In summary: Smoking -> ROS inactivate α1-antitrypsin -> unopposed elastase destroys alveolar walls -> loss of elastic recoil -> airway collapse on expiration -> air trapping, dyspnea, obstructive pattern on PFTs.
(Robbins & Kumar Basic Pathology; Murray & Nadel's Textbook of Respiratory Medicine)

CASE B - Myasthenia Gravis

Q1: Which biochemical process/molecular concept is primarily disturbed?

Autoantibody-mediated blockade and destruction of nicotinic acetylcholine receptors (nAChR) at the postsynaptic membrane of the neuromuscular junction (NMJ) is the primary disturbed mechanism.
This is a Type II (cytotoxic) hypersensitivity reaction. IgG antibodies target the alpha-subunit of the nAChR. They cause receptor loss by three mechanisms:
  1. Complement activation - antibody-complement complexes destroy the postsynaptic membrane and reduce receptor density
  2. Receptor internalization (antigenic modulation) - cross-linking of receptors by antibodies accelerates their endocytosis and degradation
  3. Functional blockade - direct steric interference with acetylcholine binding
The result is a reduced number of functional nAChRs at the motor end plate.

Q2: How does this disturbance produce the clinical/laboratory findings?

Normally, a nerve impulse releases acetylcholine (ACh) into the NMJ synapse. ACh binds to nAChRs on the muscle end plate, triggering depolarization and muscle contraction. There is a "safety margin" - far more ACh is released than is needed to fire the muscle.
With myasthenia gravis:
  • The reduced nAChR density means that during repetitive nerve stimulation, the safety margin is progressively exhausted
  • Each successive impulse has fewer receptors available (receptors desensitize after each activation, and with fewer total receptors there is not enough reserve)
  • This explains the hallmark sign: weakness that worsens with repeated muscle use (fatigability) and improves with rest
  • Clinically: ptosis, diplopia (ocular muscles most sensitive, as they fire at high frequency), limb weakness, dysphagia, dysarthria
  • Electrophysiology (repetitive nerve stimulation test): shows a characteristic decremental response in compound muscle action potential (CMAP) amplitude with repeated stimulation - direct evidence of progressive failure of neuromuscular transmission
  • Positive anti-AChR antibodies in ~85% of patients (serologic marker)
  • Edrophonium (Tensilon) test: short-acting acetylcholinesterase inhibitor transiently increases ACh concentration, briefly overcoming the receptor deficit and improving strength
In summary: Anti-AChR IgG antibodies -> complement-mediated destruction + internalization of nAChRs -> reduced end-plate receptor density -> failure of neuromuscular transmission that worsens with repeated use -> fatigable muscle weakness.
(Robbins & Kumar Pathologic Basis of Disease; Adams and Victor's Principles of Neurology; Murray & Nadel's Textbook of Respiratory Medicine)
This is a shared conversation. Sign in to Orris to start your own chat.